Loading data
CBIONasdaq
| Unit: USD | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 10.84 m USD | — | — | — | — |
| Research and development expense | 138.09 m USD | 14.26 m USD | 20.07 m USD | 28.39 m USD | 47.49 m USD |
| Operating profit | -152.63 m USD | -40.04 m USD | -39.28 m USD | -47.4 m USD | -63.45 m USD |
| Profit before tax | -151.94 m USD | — | — | — | — |
| Income tax expense | 2 m USD | — | — | — | — |
| Net income (reported basis) | 153.94 k USD | 37.88 k USD | 36.9 k USD | -46.69 m USD | -63.43 m USD |
| Net income attributable to common shareholders | -133.45 m USD | — | — | — | — |
| Basic earnings per share | — | -0.59 USD/share | -0.58 USD/share | -0.89 USD/share | -1.23 USD/share |
| Diluted earnings per share | — | -0.59 USD/share | -0.58 USD/share | -0.89 USD/share | -1.23 USD/share |
Quotes are end-of-day data. Content is for research purposes and is not investment advice.